Charles Schwab Investment Management »

Celldex Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $18M 539k 33.99
2024-06-30 $20M 530k 37.01
2024-03-31 $21M 499k 41.97
2023-12-31 $16M 409k 39.66
2023-09-30 $9.9M 362k 27.52
2023-06-30 $12M 351k 33.93
2023-03-31 $13M 347k 35.98
2022-12-31 $16M 348k 44.57
2022-09-30 $9.5M 338k 28.11
2022-06-30 $8.9M 331k 26.96
2022-03-31 $12M 337k 34.06
2021-12-31 $13M 328k 38.64
2021-09-30 $17M 323k 53.99
2021-06-30 $3.3M 98k 33.44
2021-03-31 $299k 15k 20.61
2020-12-31 $255k 15k 17.58
2020-09-30 $246k 17k 14.84